Inteliview
Log inSign up
IPO Tracker
Braveheart Bio, Inc.

Braveheart Bio, Inc.

Braveheart Bio, Inc.

USPricing
Valuation$100M
Original Target2026-07-15 (Date under review)
Sector--
Exchange--
RELATED IPOS
Hyperliquid Strategies Inc
Hyperliquid Strategies IncHyperliquid Strategies IncUS · --
R
RanMarine Technology B.V.RanMarine Technology B.V.US · --
APEX Global Solutions Ltd
APEX Global Solutions LtdAPEX Global Solutions LtdUS · --
G
GridAI Technologies Corp.GridAI Technologies Corp.US · --
HCW Biologics Inc.
HCW Biologics Inc.HCW Biologics Inc.US · --
ConnectM Technology Solutions, Inc.
ConnectM Technology Solutions, Inc.ConnectM Technology Solutions, Inc.US · --
FAQ

When is the Braveheart Bio, Inc. IPO expected?

The Braveheart Bio, Inc. IPO is currently in the Pricing stage. The originally expected date was 2026-07-15 and the process is ongoing. Timelines may change based on market conditions.

What is Braveheart Bio, Inc.'s valuation?

Braveheart Bio, Inc.'s estimated valuation is approximately $100M. The final valuation will depend on IPO pricing and market demand.

Can retail investors participate in the Braveheart Bio, Inc. IPO?

U.S. IPOs are typically allocated to institutional investors first. Retail investors can purchase shares on NYSE/NASDAQ after listing. Some brokerages offer IPO access programs for pre-IPO allocation.